Strong Biotechnologies secures new medical device registrations, expands product lines

Beijing Strong Biotechnologies Co., Ltd. recently announced the receipt of three medical device registration certificates from the Beijing Municipal Medical Products Administration. These new registrations include "D-Dimer Calibrator," "Calcitonin Assay Kit (Chemiluminescence Immunoassay for Magnetic Particles)," and "Mycophenolic Acid Assay Kit (IMPDH II Method)." All three products are classified as Class II medical devices and are valid until December 18, 2030.

The D-Dimer Calibrator is intended for use with the company's or Beijing Meichuang Xinyue Medical Device Co., Ltd.'s reagent kits for D-Dimer detection system calibration. The Calcitonin Assay Kit is for in vitro quantitative determination of calcitonin (CT) levels in human serum or plasma. The Mycophenolic Acid Assay Kit is for in vitro quantitative determination of mycophenolic acid (MPA) levels in human serum.

The company stated that obtaining these registration certificates enriches its product lines in the in vitro diagnostic biochemical, chemiluminescence, and hemagglutination sub-sectors. This development is expected to enhance Strong Biotechnologies' core competitiveness and market expansion capabilities, positively influencing its future operations. However, actual sales performance will depend on future market promotion, and the company advises investors to be aware of potential risks.